Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12501
Daktronics
DAKT
$858M
| $43.4K | ﹤0.01% |
2,573
-677
| -21% | -$10.2K |
2017 Q1
31 quarters
|
|
12502
CCSC Technology International Holdings
CCTG
$6.98M
| $43.4K | ﹤0.01% |
+2,798
| New | +$49K |
2024 Q4
0 quarters
|
|
|
AEVA
12503
CALL
Aeva Technologies
AEVA
$1.02B
| $43.2K | ﹤0.01% |
+9,100
| New | +$36.8K |
2024 Q4
0 quarters
|
|
12504
PUT
VirTra
VTSI
$31.2M
| $43.2K | ﹤0.01% |
6,400
-61,500
| -91% | -$415K |
2021 Q4
12 quarters
|
|
12505
Gaia
GAIA
$35.9M
| $43.2K | ﹤0.01% |
9,616
-6,353
| -40% | -$34.7K |
2022 Q3
9 quarters
|
|
|
EPIX
12506
CALL
DELISTED
ESSA Pharma
EPIX
| $43.1K | ﹤0.01% |
24,100
+23,400
| +3,343% | +$74.5K |
2021 Q4
12 quarters
|
|
12507
CALL
NRX Pharmaceuticals
NRXP
$127M
| $43.1K | ﹤0.01% |
19,600
-15,700
| -44% | -$21.1K |
2021 Q3
13 quarters
|
|
12508
PUT
Vanda Pharmaceuticals
VNDA
$273M
| $43.1K | ﹤0.01% |
9,000
-12,100
| -57% | -$58.1K |
2022 Q4
8 quarters
|
|
|
OLO
12509
CALL
DELISTED
Olo Inc
OLO
| $43K | ﹤0.01% |
5,600
-1,800
| -24% | -$11.2K |
2021 Q2
14 quarters
|
|
|
DENN
12510
PUT
DELISTED
Denny's
DENN
| $43K | ﹤0.01% |
7,100
+3,500
| +97% | +$22.3K |
2020 Q1
19 quarters
|
|
12511
PUT
Hilltop Holdings
HTH
$2.13B
| $42.9K | ﹤0.01% |
1,500
+1,300
| +650% | +$40.6K |
2022 Q2
10 quarters
|
|
12512
CALL
Valens Semiconductor
VLN
$204M
| $42.9K | ﹤0.01% |
+16,500
| New | +$33K |
2024 Q4
0 quarters
|
|
12513
CALL
Clear Channel Outdoor Holdings
CCO
$1.22B
| $42.7K | ﹤0.01% |
31,200
-95,200
| -75% | -$145K |
2022 Q4
8 quarters
|
|
12514
PUT
iShares North American Natural Resources ETF
IGE
$787M
| $42.7K | ﹤0.01% |
1,000
+900
| +900% | +$40.7K |
2023 Q4
4 quarters
|
|
12515
CALL
Scansource
SCSC
$1.23B
| $42.7K | ﹤0.01% |
900
-1,900
| -68% | -$92.9K |
2024 Q2
2 quarters
|
|
12516
CALL
Korea Electric Power
KEP
$14.5B
| $42.7K | ﹤0.01% |
6,200
+5,600
| +933% | +$43.8K |
2024 Q3
1 quarter
|
|
|
AXDX
12517
DELISTED
Accelerate Diagnostics
AXDX
| $42.5K | ﹤0.01% |
35,412
+22,900
| +183% | +$38K |
2024 Q3
1 quarter
|
|
12518
PUT
CoinShares Bitcoin and Ether ETF
BTF
$16.9M
| $42.5K | ﹤0.01% |
580
-6,600
| -92% | -$646K |
2024 Q2
2 quarters
|
|
12519
CALL
Betterware México
BWMX
$607M
| $42.5K | ﹤0.01% |
3,800
+3,100
| +443% | +$38K |
2023 Q2
6 quarters
|
|
12520
CALL
Global X MLP & Energy Infrastructure ETF
MLPX
$3.53B
| $42.4K | ﹤0.01% |
700
-400
| -36% | -$23.8K |
2021 Q3
13 quarters
|
|
12521
CALL
NanoViricides
NNVC
$35.7M
| $42.3K | ﹤0.01% |
29,600
+8,400
| +40% | +$12.1K |
2024 Q3
1 quarter
|
|
12522
Bolt Biotherapeutics
BOLT
$6.76M
| $42.3K | ﹤0.01% |
+3,948
| New | +$47.7K |
2024 Q4
0 quarters
|
|
12523
CALL
Toro Corp
TORO
$175M
| $42.1K | ﹤0.01% |
+15,000
| New | +$44.4K |
2024 Q4
0 quarters
|
|
12524
CALL
Oramed Pharmaceuticals
ORMP
$182M
| $42.1K | ﹤0.01% |
17,400
+13,400
| +335% | +$31.8K |
2024 Q3
1 quarter
|
|
12525
CALL
Marcus & Millichap
MMI
$1.08B
| $42.1K | ﹤0.01% |
1,100
-100
| -8% | -$3.92K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.